يعرض 17,481 - 17,500 نتائج من 18,089 نتيجة بحث عن 'significantly ((((((less decrease) OR (larger decrease))) OR (teer decrease))) OR (a decrease))', وقت الاستعلام: 0.32s تنقيح النتائج
  1. 17481

    Table 1_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... حسب Tessa Rose Cornell (15460726)

    منشور في 2024
    "…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …"
  2. 17482

    Table 2_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... حسب Tessa Rose Cornell (15460726)

    منشور في 2024
    "…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …"
  3. 17483

    Table 10_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... حسب Tessa Rose Cornell (15460726)

    منشور في 2024
    "…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …"
  4. 17484

    Table 3_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... حسب Tessa Rose Cornell (15460726)

    منشور في 2024
    "…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …"
  5. 17485

    Table 8_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... حسب Tessa Rose Cornell (15460726)

    منشور في 2024
    "…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …"
  6. 17486

    Table 6_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... حسب Tessa Rose Cornell (15460726)

    منشور في 2024
    "…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …"
  7. 17487

    Table 5_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... حسب Tessa Rose Cornell (15460726)

    منشور في 2024
    "…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …"
  8. 17488

    Table 4_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... حسب Tessa Rose Cornell (15460726)

    منشور في 2024
    "…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …"
  9. 17489

    Table 7_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... حسب Tessa Rose Cornell (15460726)

    منشور في 2024
    "…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …"
  10. 17490

    Table_2_Microclimate shapes the phylosymbiosis of rodent gut microbiota in Jordan’s Great Rift Valley.XLSX حسب Enas Al-khlifeh (17286364)

    منشور في 2025
    "…We found that bioclimatic zone had a significant effect on the gut microbiota composition while host phylogeny did not. …"
  11. 17491

    Supplementary file 1_Structural and functional disconnections in non-acute post-stroke patients.docx حسب Yanan Wu (290695)

    منشور في 2025
    "…</p>Results<p>Compared with HCs, significant decreases in both SC and FC were observed in stroke patients among the right precentral gyrus, right superior frontal gyrus, right supplementary motor area, right paracentral lobule, right middle cingulate gyrus, right superior marginal gyrus, right middle temporal gyrus, and left inferior temporal gyrus. …"
  12. 17492

    Table 4_Analysis of global trends in acute lymphoblastic leukemia in children aged 0–5 years from 1990 to 2021.docx حسب Fang Ding (222713)

    منشور في 2025
    "…Background<p>Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with a significant global burden. This study evaluates global, regional, and national trends in the prevalence, mortality, and disability-adjusted life years (DALYs) of childhood ALL from 1990 to 2021, providing insights into disparities and progress across different socio-demographic and geographic contexts.…"
  13. 17493

    DataSheet1_CircFOXO3 upregulation mediates the radioresistance of glioblastoma by affecting cellular metabolome.DOCX حسب Hao Xu (6530)

    منشور في 2024
    "…Introduction<p>Radioresistance remains a significant challenge in the treatment of glioblastoma multiforme (GBM), the most prevalent and lethal brain cancer in adults. …"
  14. 17494

    Table1_CircFOXO3 upregulation mediates the radioresistance of glioblastoma by affecting cellular metabolome.XLSX حسب Hao Xu (6530)

    منشور في 2024
    "…Introduction<p>Radioresistance remains a significant challenge in the treatment of glioblastoma multiforme (GBM), the most prevalent and lethal brain cancer in adults. …"
  15. 17495

    Table_1_Microclimate shapes the phylosymbiosis of rodent gut microbiota in Jordan’s Great Rift Valley.XLSX حسب Enas Al-khlifeh (17286364)

    منشور في 2025
    "…We found that bioclimatic zone had a significant effect on the gut microbiota composition while host phylogeny did not. …"
  16. 17496

    Image 1_Analysis of global trends in acute lymphoblastic leukemia in children aged 0–5 years from 1990 to 2021.tif حسب Fang Ding (222713)

    منشور في 2025
    "…Background<p>Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with a significant global burden. This study evaluates global, regional, and national trends in the prevalence, mortality, and disability-adjusted life years (DALYs) of childhood ALL from 1990 to 2021, providing insights into disparities and progress across different socio-demographic and geographic contexts.…"
  17. 17497

    Table 2_Analysis of global trends in acute lymphoblastic leukemia in children aged 0–5 years from 1990 to 2021.docx حسب Fang Ding (222713)

    منشور في 2025
    "…Background<p>Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with a significant global burden. This study evaluates global, regional, and national trends in the prevalence, mortality, and disability-adjusted life years (DALYs) of childhood ALL from 1990 to 2021, providing insights into disparities and progress across different socio-demographic and geographic contexts.…"
  18. 17498

    Table 1_Analysis of global trends in acute lymphoblastic leukemia in children aged 0–5 years from 1990 to 2021.docx حسب Fang Ding (222713)

    منشور في 2025
    "…Background<p>Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with a significant global burden. This study evaluates global, regional, and national trends in the prevalence, mortality, and disability-adjusted life years (DALYs) of childhood ALL from 1990 to 2021, providing insights into disparities and progress across different socio-demographic and geographic contexts.…"
  19. 17499

    Table 3_Analysis of global trends in acute lymphoblastic leukemia in children aged 0–5 years from 1990 to 2021.docx حسب Fang Ding (222713)

    منشور في 2025
    "…Background<p>Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with a significant global burden. This study evaluates global, regional, and national trends in the prevalence, mortality, and disability-adjusted life years (DALYs) of childhood ALL from 1990 to 2021, providing insights into disparities and progress across different socio-demographic and geographic contexts.…"
  20. 17500

    Figure 2 from Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in <i>EGFR</i>- and <i>KRAS</i>-Mutant Lung Cancer حسب Xiaoxiao Sun (20589448)

    منشور في 2025
    "…<b>A</b> and <b>B,</b> Cells were treated with type I PRMT inhibitors (PRMTi) at 0.1 or 1 μmol/L, with (<b>A</b>) or without (<b>B</b>) targeted drugs. …"